Bilirubin is independently associated with oxidized LDL levels in young obese patients

Detalhes bibliográficos
Autor(a) principal: Nascimento, H.
Data de Publicação: 2015
Outros Autores: Alves, A., Coimbra, S., Catarino, C., Gomes, D., Bronze-da-Rocha, E., Costa, E., Rocha-Pereira, P., Aires, L., Mota, J., Mansilha, H., Rêgo, C., Santos-Silva, A., Belo, L.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.16/1971
Resumo: BACKGROUND: Bilirubin can prevent lipid oxidation in vitro, but the association in vivo with oxidized low-density lipoprotein (Ox-LDL) levels has been poorly explored. Our aim is to the association of Ox-LDL with total bilirubin (TB) levels and with variables related with metabolic syndrome and inflammation, in young obese individuals. FINDINGS: 125 obese patients (13.4 years; 53.6% females) were studied. TB, lipid profile including Ox-LDL, markers of glucose metabolism, and levels of C-reactive protein (CRP) and adiponectin were determined. Anthropometric data was also collected. In all patients, Ox-LDL correlated positively with BMI, total cholesterol, LDLc, triglycerides (TG), CRP, glucose, insulin and HOMAIR; while inversely with TB and HDLc/Total cholesterol ratio (P < 0.05 for all). In multiple linear regression analysis, LDLc, TG, HDLc and TB levels were significantly associated with Ox-LDL (standardized Beta: 0.656, 0.293, -0.283, -0.164, respectively; P < 0.01 for all). After removing TG and HDLc from the analysis, HOMAIR was included in the regression model. In this new model, LDLc remained the best predictor of Ox-LDL levels (β = 0.665, P < 0.001), followed by TB (β = -0.202, P = 0.002) and HOMAIR (β = 0.163, P = 0.010). CONCLUSIONS: Lower bilirubin levels may contribute to increased LDL oxidation in obese children and adolescents, predisposing to increased cardiovascular risk.
id RCAP_d256e314ce96100092478d335939819a
oai_identifier_str oai:repositorio.chporto.pt:10400.16/1971
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Bilirubin is independently associated with oxidized LDL levels in young obese patientsBilirubinOxidized-LDLOxidative stressAtherosclerosisPediatric obesityBACKGROUND: Bilirubin can prevent lipid oxidation in vitro, but the association in vivo with oxidized low-density lipoprotein (Ox-LDL) levels has been poorly explored. Our aim is to the association of Ox-LDL with total bilirubin (TB) levels and with variables related with metabolic syndrome and inflammation, in young obese individuals. FINDINGS: 125 obese patients (13.4 years; 53.6% females) were studied. TB, lipid profile including Ox-LDL, markers of glucose metabolism, and levels of C-reactive protein (CRP) and adiponectin were determined. Anthropometric data was also collected. In all patients, Ox-LDL correlated positively with BMI, total cholesterol, LDLc, triglycerides (TG), CRP, glucose, insulin and HOMAIR; while inversely with TB and HDLc/Total cholesterol ratio (P < 0.05 for all). In multiple linear regression analysis, LDLc, TG, HDLc and TB levels were significantly associated with Ox-LDL (standardized Beta: 0.656, 0.293, -0.283, -0.164, respectively; P < 0.01 for all). After removing TG and HDLc from the analysis, HOMAIR was included in the regression model. In this new model, LDLc remained the best predictor of Ox-LDL levels (β = 0.665, P < 0.001), followed by TB (β = -0.202, P = 0.002) and HOMAIR (β = 0.163, P = 0.010). CONCLUSIONS: Lower bilirubin levels may contribute to increased LDL oxidation in obese children and adolescents, predisposing to increased cardiovascular risk.BioMed CentralRepositório Científico do Centro Hospitalar Universitário de Santo AntónioNascimento, H.Alves, A.Coimbra, S.Catarino, C.Gomes, D.Bronze-da-Rocha, E.Costa, E.Rocha-Pereira, P.Aires, L.Mota, J.Mansilha, H.Rêgo, C.Santos-Silva, A.Belo, L.2016-07-26T11:46:52Z20152015-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.16/1971engDiabetol Metab Syndr. 2015 Jan 23;7:41758-599610.1186/1758-5996-7-4info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-10-20T10:58:27Zoai:repositorio.chporto.pt:10400.16/1971Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:38:16.662633Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Bilirubin is independently associated with oxidized LDL levels in young obese patients
title Bilirubin is independently associated with oxidized LDL levels in young obese patients
spellingShingle Bilirubin is independently associated with oxidized LDL levels in young obese patients
Nascimento, H.
Bilirubin
Oxidized-LDL
Oxidative stress
Atherosclerosis
Pediatric obesity
title_short Bilirubin is independently associated with oxidized LDL levels in young obese patients
title_full Bilirubin is independently associated with oxidized LDL levels in young obese patients
title_fullStr Bilirubin is independently associated with oxidized LDL levels in young obese patients
title_full_unstemmed Bilirubin is independently associated with oxidized LDL levels in young obese patients
title_sort Bilirubin is independently associated with oxidized LDL levels in young obese patients
author Nascimento, H.
author_facet Nascimento, H.
Alves, A.
Coimbra, S.
Catarino, C.
Gomes, D.
Bronze-da-Rocha, E.
Costa, E.
Rocha-Pereira, P.
Aires, L.
Mota, J.
Mansilha, H.
Rêgo, C.
Santos-Silva, A.
Belo, L.
author_role author
author2 Alves, A.
Coimbra, S.
Catarino, C.
Gomes, D.
Bronze-da-Rocha, E.
Costa, E.
Rocha-Pereira, P.
Aires, L.
Mota, J.
Mansilha, H.
Rêgo, C.
Santos-Silva, A.
Belo, L.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Centro Hospitalar Universitário de Santo António
dc.contributor.author.fl_str_mv Nascimento, H.
Alves, A.
Coimbra, S.
Catarino, C.
Gomes, D.
Bronze-da-Rocha, E.
Costa, E.
Rocha-Pereira, P.
Aires, L.
Mota, J.
Mansilha, H.
Rêgo, C.
Santos-Silva, A.
Belo, L.
dc.subject.por.fl_str_mv Bilirubin
Oxidized-LDL
Oxidative stress
Atherosclerosis
Pediatric obesity
topic Bilirubin
Oxidized-LDL
Oxidative stress
Atherosclerosis
Pediatric obesity
description BACKGROUND: Bilirubin can prevent lipid oxidation in vitro, but the association in vivo with oxidized low-density lipoprotein (Ox-LDL) levels has been poorly explored. Our aim is to the association of Ox-LDL with total bilirubin (TB) levels and with variables related with metabolic syndrome and inflammation, in young obese individuals. FINDINGS: 125 obese patients (13.4 years; 53.6% females) were studied. TB, lipid profile including Ox-LDL, markers of glucose metabolism, and levels of C-reactive protein (CRP) and adiponectin were determined. Anthropometric data was also collected. In all patients, Ox-LDL correlated positively with BMI, total cholesterol, LDLc, triglycerides (TG), CRP, glucose, insulin and HOMAIR; while inversely with TB and HDLc/Total cholesterol ratio (P < 0.05 for all). In multiple linear regression analysis, LDLc, TG, HDLc and TB levels were significantly associated with Ox-LDL (standardized Beta: 0.656, 0.293, -0.283, -0.164, respectively; P < 0.01 for all). After removing TG and HDLc from the analysis, HOMAIR was included in the regression model. In this new model, LDLc remained the best predictor of Ox-LDL levels (β = 0.665, P < 0.001), followed by TB (β = -0.202, P = 0.002) and HOMAIR (β = 0.163, P = 0.010). CONCLUSIONS: Lower bilirubin levels may contribute to increased LDL oxidation in obese children and adolescents, predisposing to increased cardiovascular risk.
publishDate 2015
dc.date.none.fl_str_mv 2015
2015-01-01T00:00:00Z
2016-07-26T11:46:52Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.16/1971
url http://hdl.handle.net/10400.16/1971
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Diabetol Metab Syndr. 2015 Jan 23;7:4
1758-5996
10.1186/1758-5996-7-4
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133644135071744